Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced that following value driving opportunities for 2011.Maximize the value of Amylin's established diabetes franchise ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE